- GI is exploding with new tech—but how do patients feel about it?
- HHS, CMS form healthcare advisory committee
- NewYork-Presbyterian named in antitrust lawsuit
- Maryland physician to pay $500K+ to settle false claims allegations
- FirstHealth breaks ground on $43M replacement hospital
- Rhode Island oral surgeon launches Congressional campaign
- Johns Hopkins affiliate names new CEO
- 6 things to know about the pharmacy technician workforce
- FDA adds seizure warning to CSL flu vaccine label
- Premier Anesthesia, City of Hope Phoenix ink partnership
- 20 behavioral health leaders challenge industry assumptions
- Why an $8B health system recommitted to its original name
- What simulation training revealed about GI skills gaps
- Judge dismisses physician’s wrongful termination suit against staffing firm
- 3 California behavioral health centers to close amid funding shifts
- Missouri system taps CFO as COO
- HCA moves to block disclosure of physician, patient outcomes post-hospital acquisition
- 6 things to know about CMS’ GLP-1 pilot model: KFF
- North Carolina practice to close after 40+ years
- St. Tammany opens outpatient cardiology center
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- 6 dental practice openings to know
- APRNs, PAs account for most antipsychotic prescriptions for Medicare Part D: Study
- What will surprise ASC leaders about spine in 5 years?
- Why culture is the secret to a high-performing ASC
- Oklahoma House passes bill expanding scope of dental assistants
- Dr. Nellie Kim-Weroha joins American Association of Orthodontists’ Board of Trustees
- California behavioral health agency to close 2 centers
- Cardiologist named chief medical officer of biotech company
- St. Luke’s CFO joins RCM company’s advisory board
- 52 DSOs to know: 2026
- 10 hospitals, health systems looking for CFOs
- 10 health system rating downgrades
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- North Star’s restructuring moves forward
- Illinois hospital pauses patient care amid payroll challenges
- What the Best-Performing Revenue Cycles Have in Common
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- California peer-run behavioral health center to close amid funding shift
- Remarks at the Financial Stability Oversight Council Meeting
- ‘Integration only works if data lives in the same system’: How 5 systems are operationalizing behavioral health
- Medicaid work rules and enrollment losses: 6 notes
- Inside UHS’ playbook for responsible behavioral health growth
- Epic4 Specialty Partners adds Illinois practice
- Adventist Health cuts operating loss in 2025
- ‘Burning the candle from both ends’: New York hospital CFO on rising costs, revenue cuts
- The unsolved problems still plaguing dentistry
- American Dental Association adds mental health, GLP-1 prompts to patient forms
- 21 revenue cycle executive moves in 2026
- North Carolina orthodontic practice opens 7th location
- Virginia hospital boosts workplace safety reporting 245% with 3 strategic shifts
- ADA urges CMS to proceed with adult dental coverage expansion
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- Imagen Dental Partners adds Washington practice
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
- Lilly to remove certain insulin products from European markets by 2027
- Karyopharm, looking to jump-start Xpovio, reports mixed results in myelofibrosis
- Study Warns Fluoride Bans May Raise Tooth Decay in Children
- WuXi Bio's record number of new projects in 2025 leaned heavily on US clients
- “Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos
- Gilead inks Manta pact to dive deeper into cancer patient support
- Cheap Children's Clothing Tainted With Lead, Study Says
- Insulin Prices Fell For Medicare Patients Under Biden-Era Caps, Study Finds
- New Fathers Face Mental Health Challenges, Study Finds
- Your Choice Of Booze Influences Your Risk Of Death, Study Says
- AI Gets a 'D' When Judging Scientific, Medical Claims
- New Online Tool Helps Parkinson's Patients Weigh Brain Implant Decision
- AI chatbot use for health information up 16% from 2024: Rock Health survey
- ‘They Tricked Me’: A Father Was Chained After He Went to ICE To Reunite With His Kids
- Wilmington PharmaTech commits $50M to US API expansion
- Strides recalls nearly 90K bottles of children's ibuprofen after contamination complaints
- Trump administration unveils national policy framework for AI as it moves to override state laws
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- 17 spine surgery firsts in Q1
- 17 spine surgery firsts in Q1
- Cencora acquiring EyeSouth Partners' retina business for $1.1B
- Aunque tengas seguro dental, la factura puede ser muy alta
- Massive class action seeking RICO penalties against Takeda, Lilly presses forward with SCOTUS order
- A look at how Optum Rx is using AI to address pharmacy fraud, waste and abuse
- Nursing Homes Accused of False Diagnoses To Hide Drug Use
- FDA Approves Higher-Dose Wegovy To Help People Lose More Weight
- Teens Often Pressured To Send Sexual Photos by Someone They Know, Study Finds
- CommonSpirit, Humana reach 3-year national network agreement
- Match Day 2026: Growth in emergency medicine, psychiatry
- Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide
- FTC launches multi-bureau Healthcare Task Force to spot 'new priority areas for enforcement'
- Algunos adultos de mediana edad deciden posponer la atención médica hasta tener Medicare
- ¿Qué tan bajo se puede llegar? Las cambiantes guías para el control de la presión arterial
- Rural hospitals could apply for temporary interest-free construction, renovation loans under new bipartisan bill
- Rural Residents Have Highest Cancer Death Rates, Researchers Say
- Your Bank Account Might Show How Well Your Brain Will Age, Researchers Say
- Insurance Lapses Play Havoc With Diabetes Management, Study Shows
- Psychedelics Aren't Better Than Antidepressants In Treating Depression, Review Concludes
- A Nasal Swab for Alzheimer's? Duke Team Has One in Testing
This is how you get your Cabinet nominees confirmed, double quick time, without histrionics. The Democrats stalling RFK, Jr. just ran out of slack. From Gizmodo, a mouthpiece of the left:
https://gizmodo.com/trump-orders-cdc-fda-and-other-health-agencies-to-go-dark-2000553437
Trump Orders CDC, FDA, and Other Health Agencies to Go Dark
The communications pause could be an early sign of things to come under a renewed Trump White House.
By Ed Cara | January 22, 2025The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the U.S. Department of Health and Human Services. This week, the returning Trump administration told these agencies to stop talking to the public—for how long, no one knows.
The Washington Post first broke news of Trump’s sweeping directive late Tuesday evening. Staff at these agencies have been reportedly ordered to cease external communication for the time being. The move is the latest to unnerve outside experts about the direction of the country’s public health infrastructure under Trump.
The order was delivered by Stefanie Spear, a newly hired deputy chief of staff at HHS, according to the Post. Spear was the press secretary for Robert F. Kennedy Jr. during his 2024 presidential campaign, who has since been nominated by Trump to lead HHS. Affected staff told the Post that the directive lacked specific details, including the reasoning behind it, how long the pause is expected to last, and whether there are any exceptions allowed.
Gizmodo reached out to the HHS for comment but did not hear back by the time of publication.
It’s certainly possible that the White House is simply trying to make it easier for its new health officials to transition into their roles. And this isn’t an unprecedented action for the White House to take to accomplish that, according to Carmen Marsit, executive associate dean at Emory University’s Rollins School of Public Health.
“It is not uncommon for a new administration to ask for a pause on communications, website updates, etc, in order for new leadership to review the information, understand how information flows, and then work to continue communications,” Marsit told Gizmodo in an email. At the same time, he added, the scope of this directive is currently unknown, as is its potential impact on the public.
Emerging outbreaks, new discoveries, and noteworthy drug approvals are just some of the many things that agencies like the CDC and FDA regularly communicate to the general public and clinicians. Research led by or conducted with the help of government scientists is also routinely published in the CDC’s Morbidity and Mortality Weekly Report (MMWR), which has often served as an early look into important health trends and crises (the first reported cases of what came to be known as HIV/AIDS, for instance). According to the Post, CDC staff were planning to publish several reports in the MMWR this week, including three concerning H5N1—a highly pathogenic strain of avian influenza that has increasingly started to infect cattle, other mammals, and humans since last year.
Halting communication from federal health agencies like the CDC, NIH, and FDA during an administration transition is highly problematic, especially with active public health threats like the H5N1 outbreak in the U.S. and the Marburg outbreak in Tanzania, according to Krutika Kuppalli, an infectious disease physician in Dallas with experience in global health and pandemic preparedness.
“A blanket suspension of external communication from health agencies is unusual and potentially harmful,” Kuppalli told Gizmodo. “Trust in institutions like the CDC is built on transparency and reliability. A lack of communication could lead to skepticism or distrust, making it harder to re-establish credibility when communication resumes.”
There’s also past history to consider, as the Trump-led White House has a track record of muzzling its federal agencies and scientists. In the early days of Trump’s first term, the administration similarly ordered several agencies, including the United States Department of Agriculture, to temporarily stay quiet (much of this directive was quickly revised, however). More worryingly, the Trump administration prevented health officials from communicating with the press and public in the early months of the covid-19 pandemic, while his staff reportedly later tried to alter reports from the CDC concerning covid-19—allegedly with the goal of downplaying the harms of the pandemic.
The potential next leader of HHS, RFK Jr., has also made it clear that he wants to dramatically change the direction of the country’s public health agencies, and likely not for the better. RFK Jr. has regularly espoused false or misleading statements about vaccines and other health-related topics, for instance, and he’s promised to suspend government-led research on infectious diseases if given the chance. And earlier this week, Trump signed an executive order reinstating his plan to have the U.S. leave the World Health Organization, which has played a vital role in supporting public health globally.
“The CDC collaborates with international partners to tackle global health challenges,” noted Kuppalli, who has previously worked with the WHO as a medical officer on covid-19. “The planned withdrawal from WHO already has implications for the U.S.’ role in global health, but a communication freeze could further undermine the U.S.’ reputation as a leader in public health.”
Should this pause linger on, it may be an early indication that the CDC and other agencies will face new challenges from the Trump administration that might prevent them from communicating honestly with the public. And that’s likely to bode very badly for the rest of us.
“While it is the prerogative of any administration to align federal agencies with their vision and goals, public health must remain a nonpartisan priority,” Kuppalli said. “Ensuring continuity of communication from agencies like the CDC, FDA and NIH during transitional periods is not only wise but essential for safeguarding the health and well-being of the public.”
Federal health employee travel has been curtailed. Participation in and sponsorship of external meetings has also been suspended:
US health agencies cancel external meetings, travel after Trump admin directives
By Julie Steenhuysen - January 23, 2025Summary
* 'One Health' bird flu call canceled this week -source
* Travel ban enacted for all health agency employees
* CDC weekly publication of scientific reports did not publish on ThursdayCHICAGO, Jan 23 (Reuters) - U.S. health agencies including the CDC this week canceled meetings with external groups, paused some public health publications and told employees to freeze travel after directives from the Department of Health and Human Services, two sources familiar with the situation said.
On Wednesday, a state/federal call scheduled for Thursday involving states affected by H5N1 bird flu in dairy cattle and other animals was canceled, one of the sources said. It also postponed a training session for public health practitioners, the source said.
The source said the H5N1 bird flu calls occur on a regular schedule, and was aware only that the Thursday session, which was designated a "One Health" call involving both human and animal health issues, was canceled.
Presidential transitions often involve some pause in communications but the source characterized the current scope as broad.
South Dakota's state veterinarian Beth Thompson confirmed that the Centers for Disease Control and Prevention on Wednesday canceled an upcoming, regularly scheduled call with state veterinarians that would normally focus on bird flu. "There was no reason given," she said.
However, the U.S. Department of Agriculture did hold a regularly scheduled call on Wednesday on tracing the location of diseased or at-risk animals through its Veterinary Services program, Thompson said.
Scientists and public health officials are growing increasingly concerned about the spread of H5N1 bird flu, which has infected nearly 70 people in the U.S. since April. Most cases have been mild and occurred in farm workers, according to the CDC.
Earlier this month, however, the United States reported its first death from bird flu after an older person was exposed to a combination of backyard chickens and wild birds.
The cancellations followed a memo from acting HHS Secretary Dorothy Fink seen by Reuters that called for an immediate pause on issuing documents and public communications, including on any speaking engagements until the material has been reviewed and approved by a presidential appointee.
The pause is intended to extend through Feb. 1.
HHS said in a statement that its pause was for public communications not directly related to emergencies or critical to preserving health, and said exceptions for mission critical communications would be made on a case-by-case basis.
A travel ban directive was sent in a Jan. 21 memo to financial officers and travel officials within all operating divisions of HHS, including the National Institutes of Health, the Food and Drug Administration and the CDC, according to an HHS official who was not authorized to speak publicly on the matter.
The travel ban is in effect until further notice, according to the HHS official, who read portions of the memo to Reuters.
It specifies that any speaking engagements that had been accepted prior to Jan. 20 must be canceled.
Travel is only authorized for people who have already departed on an official trip, and the traveler must return to the original point of departure.
Employees from the Indian Health Service are exempted from the suspension.
While a few health communications have been issued since the ban – the FDA on Wednesday put out details of a new safety warning on a drug, for instance – others were canceled.
FIRST PAUSE SINCE 1960
The CDC's Morbidity and Mortality Weekly report, or MMWR, which includes scientific reports from the agency and outside scientists, was not published on Thursday as planned. HHS did not comment on when publication would resume.
In a post on X, former CDC director Dr. Tom Frieden said the MMWR, which is used to inform health officials about emerging threats, had been published weekly without pause since 1960. Delays in its publication put Americans' health at risk, Frieden said.
Dr. Jeremy Faust, a Boston-based emergency physician and author of the Inside Medicine newsletter published on the Substack platform, said the NIH was told to halt the process that approves funding for new scientific and medical research, citing an email shown to him by an NIH official.
The memo noted that all such advisory meetings had been canceled, but noted that such work would be rescheduled.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















